TrialBMC medicine2026

Phase 1 randomized trial of HS-10353, a novel GABA(A) positive allosteric modulator for treatment of major depressive disorder.

Zhenlei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.